Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization.

Drug Des Devel Ther · 2015 · PMC4607057 · PMID 26487801

Europe PMC DOI

hedged sentences

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP <0.0001actually significant

We demonstrated that sublingual DHEA administration (50 mg daily) increased free testosterone, total testosterone, androstenedione, and DHEAS levels in a highly significant manner ( P <0.0001).

also in 132,142 other papers

a decreasing trendno p-value reported

However, there was a decreasing trend in DHEAS level noted for patients 35 years and above, but this was not significantly different from the average DHEAS level for individuals below 35 years.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.